These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

357 related items for PubMed ID: 28390410

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis.
    Sutherland L, Macdonald JK.
    Cochrane Database Syst Rev; 2006 Apr 19; (2):CD000544. PubMed ID: 16625537
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis.
    Sutherland L, Macdonald JK.
    Cochrane Database Syst Rev; 2006 Apr 19; (2):CD000543. PubMed ID: 16625536
    [Abstract] [Full Text] [Related]

  • 13. The role of aminosalicylates in the treatment of ulcerative colitis.
    Van Assche G, Baert F, De Reuck M, De Vos M, De Wit O, Hoang P, Louis E, Mana F, Pelckmans P, Rutgeerts P, Van Gossum A, D'Haens G.
    Acta Gastroenterol Belg; 2002 Apr 19; 65(4):196-9. PubMed ID: 12619425
    [Abstract] [Full Text] [Related]

  • 14. Once-daily MMX(®) mesalamine for endoscopic maintenance of remission of ulcerative colitis.
    D'Haens G, Sandborn WJ, Barrett K, Hodgson I, Streck P.
    Am J Gastroenterol; 2012 Jul 19; 107(7):1064-77. PubMed ID: 22565161
    [Abstract] [Full Text] [Related]

  • 15. Efficacy and safety of oral Pentasa (prolonged-release mesalazine) in mild-to-moderate ulcerative colitis: a systematic review and meta-analysis.
    Paridaens K, Fullarton JR, Travis SPL.
    Curr Med Res Opin; 2021 Nov 19; 37(11):1891-1900. PubMed ID: 34404286
    [Abstract] [Full Text] [Related]

  • 16. Oral and topical 5-aminosalicylic acid (mesalazine) in inducing and maintaining remission in mild-moderate relapse of ulcerative colitis: one-year randomised multicentre trial.
    Paoluzi P, D'Albasio G, Pera A, Bianchi Porro G, Paoluzi OA, Pica R, Cottone M, Miglioli M, Prantera C, Sturniolo G, Ardizzone S.
    Dig Liver Dis; 2002 Nov 19; 34(11):787-93. PubMed ID: 12546514
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Long-term safety and tolerability of once-daily mesalamine granules in the maintenance of remission of ulcerative colitis.
    Lichtenstein GR, Barrett AC, Bortey E, Paterson C, Forbes WP.
    Inflamm Bowel Dis; 2014 Aug 19; 20(8):1399-406. PubMed ID: 24874460
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.